EZEsther Van Zimmeren

Esther Van Zimmeren

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Esther Van Zimmeren has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Trust and social capital in the design and evolution of institutions for collective action

    by Benjamin Six, Esther Van Zimmeren, Florin Popa, Christine Frison


  • Patent pools and clearinghouses in the life sciences

    by Esther van Zimmeren, Sven Vanneste, Gert Matthijs, Wim Vanhaverbeke, Geertrui Van Overwalle


  • Gene Patents and Collaborative Licensing Models

    by Geertrui van Overwalle, Jean-Jacques Cassiman, Birgit Verbeure, Lawrence A. Horn, Carmen E. Correa, Jorge A. Goldstein, Esther van Zimmeren, James L. Edwards, Dirk Avau, Alan B. Bennett, et al.

    Concerns have been expressed that gene patents might result in restricted access to research and health care. The exponential growth of patents claiming human DNA sequences might result in patent thickets, royalty stacking and, ultimately, a 'tragedy of the anti-commons' in genetics. The essays in this book explore models designed to render patented genetic inventions accessible for further use in research, diagnosis or treatment. The models include patent pools, clearing house mechanisms, open source structures and liability regimes. They are analysed by scholars and practitioners in genetics, law, economics and philosophy. The volume looks beyond theoretical and scholarly analysis by conducting empirical investigation of existing examples of collaborative licensing models. Those models are examined from a theoretical perspective and tested in a set of operational cases. This combined approach is unique in its kind and prompts well founded and realistic solutions to problems in the current gene patent landscape.


  • Open Access

    Dealing with patent fragmentation in ICT and genetics: Patent pools and clearing houses

    by Geertrui Van Overwalle, Esther Van Zimmeren, Birgit Verbeure, Gert Matthijs

    Recent years have shown a remarkable increase of patents in the field of ICT and genetics. The omnipresence of patents in those areas has raised serious concerns about access to and use of ICT and genome related inventions, as the expansion of patents in those fields might result in a patent thicket. Collaborative licensing models, such as patent pools and clearing houses, have attracted great attention, as they might serve as a mechanism to deal with patent thickets in ICT and genetics and facilitate access to ICT and genomic patents. It remains to be seen to what extent the lessons from the collaborative rights experiments in ICT and genetics, can be applied in a cyberinfrastructure setting.


  • Open Access

    A clearing house for diagnostic testing: the solution to ensure access to and use of patented genetic inventions?

    by Esther Van Zimmeren, Birgit Verbeure, Gert Matthijs, Geertrui Van Overwalle

    In genetic diagnostics, the emergence of a so-called "patent thicket" is imminent. Such an overlapping set of patent rights may have restrictive effects on further research and development of diagnostic tests, and the provision of clinical diagnostic services. Currently, two models that may facilitate access to and use of patented genetic inventions are attracting much debate in various national and international fora: patent pools and clearing houses. In this article, we explore the concept of clearing houses. Several types of clearing houses are identified. First, we describe and discuss two types that would provide access to information on the patented inventions: the information clearing house and the technology exchange clearing house. Second, three types of clearing houses are analysed that not only offer access to information but also provide an instrument to facilitate the use of the patented inventions: the open access clearing house, the standardized licences clearing house and the royalty collection clearing house. A royalty collection clearing house for genetic diagnostic testing would be the most comprehensive as it would serve several functions: identifying patents and patent claims essential to diagnostic testing, matching licensees with licensors, developing and supplying standardized licences, collecting royalties, monitoring whether users respect licensing conditions, and providing dispute resolution services such as mediation and arbitration. In this way, it might function as an effective model for users to facilitate access to and use of the patented inventions. However, it remains to be seen whether patent holders with a strong patent portfolio will be convinced by the advantages of the royalty collection clearing house and be willing to participate.